Additional information
| Active substance | Lisinopril |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood pressure monitoring, kidney function tests, and electrolyte levels |
| Also known as | Lisinopril |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Effectively lowers systolic and diastolic blood pressure |
| Trade name | Prinivil, Zestril |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
| Formula | C21H31N3O5 |
| Substance class | ACE inhibitor |
| Main action | Lowers blood pressure by inhibiting the angiotensin-converting enzyme |
| Half-life | Approximately 12 hours |
| Dosage (medical) | Typically starts at 10 mg once daily, may increase to 20-40 mg daily based on response |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Reduces blood pressure, improves symptoms of heart failure |
| Side effects | Cough, dizziness, headache, extreme low blood pressure, kidney dysfunction, hyperkalemia |
| Use in sports | None, not a performance-enhancing drug |
| Manufacturer | Sanofi |
Reviews
There are no reviews yet.